GlassScriptPhysician profile
Sara J Patterson
NPI 1942295662
$1,948.89
in general payments reported to CMS, 2019-2025
20 companies · $269 in 2025
The $269 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $213 · 2021: $320 · 2022: $415 · 2023: $241 · 2024: $255 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $422.19 | 2019-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $254.30 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $171.41 | 2019-2025 | |
| Glaxosmithkline, LLC. | $151.54 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $133.48 | 2021-2023 | Qelbree |
| Corium, LLC | $131.10 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $121.86 | 2021-2025 | Vaxneuvance, Enflonsia, Vaxelis |
| Sobi, INC | $115.24 | 2019-2023 | |
| Sanofi Pasteur INC. | $77.33 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $67.79 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $57.83 | 2019-2020 | |
| Cranial Technologies, INC | $53.09 | 2023 | Doc Band |
| Adlon Therapeutics L.P. | $40.56 | 2020-2021 | |
| Seqirus USA INC | $38.08 | 2021-2022 | |
| Astellas Pharma US INC | $29.69 | 2025 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.04 | 2024 | Flumist Quadrivalent |
| Novo Nordisk INC | $19.91 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.29 | 2020 | |
| Rhodes Pharmaceuticals L.P. | $12.82 | 2019 | |
| Genentech USA, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.